ARTIDIS Meets Primary Endpoints in First Prospective Study

Our portfolio company ARTIDIS announces today promising data from their first prospective study conducted at the Breast Center in Basel, Switzerland. The spin-off from the Biozentrum at the University of Basel has succesfully developed the first nanomechanical biomarker for cancer diagnosis and treatment optimization.  HEMEX AG is a privately-owned Swiss investment and consulting company headquartered […]

DayOne supports 6 digital health startups

DayOne accelerator program for digital health startups

Following their hard work in developing innovative solutions that promote the health of children and young people, 6 digital health startups:Zoundream, Haako, Rekonas (eTomo), Wello Health, Virtual Doctors and Nutrix, were selected for DayOne Accelerator program, which is managed by BaselArea.swiss. At HEMEX, we are especially proud of our partners from Haako, Moritz Dietsche and […]

HEMEX Pitch Series

Swiss startup Scailyte CEO Peter Nestorov presenting at Hemex pitch event

At HEMEX, we regularly organize invitation-only pitch days, where selected startups get the opportunity to pitch in front of potential investors. The focus of our last 2019 pitch session was on startups seeking to revolutionize cancer diagnosis and treatment. Thank you Christina Vallgren, Marcus Palm, Martin Stauber, Seline Eisenring, Michael Krauthammer and Peter Nestorov for […]

HEMEX expands to China

On 14th November 2019, our CEO Pascal Winnen signed a cooperation agreement with the Luoyang Science and Innovation Park in Henan, China’s most populated province. Under the Agreement, HEMEX will support the property developer Forton Group with attracting innovative Swiss startups for its newly built 133’000 m2 life science park. In exchange, HEMEX and its […]